Author/Authors :
Joya, Ana Experimental Molecular Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain , Padro, Daniel Magnetic Resonance Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain , Gomez-Vallejo, Vanessa Radiochemistry and Nuclear Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain , Plaza-Garcıa, Sandra Magnetic Resonance Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain , Llop, Jordi Radiochemistry and Nuclear Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain , Martın, Abraham Experimental Molecular Imaging - Molecular Imaging Unit - CIC biomaGUNE - San Sebastian, Spain
Abstract :
Crossed cerebellar diaschisis (CCD) is a decrease of regional blood flow and metabolism in the cerebellar hemisphere contralateral
to the injured brain hemisphere as a common consequence of stroke. Despite CCD has been detected in patients with stroke using
neuroimaging modalities, the evaluation of this phenomenon in rodent models of cerebral ischemia has been scarcely evaluated so
far. Here, we report the in vivo evaluation of CCD after long-term cerebral ischemia in rats using positron emission tomography
(PET) imaging with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG). Imaging studies were combined with neurological evaluation
to assess functional recovery. In the ischemic territory, imaging studies showed a signicant decrease in glucose metabolism
followed by a progressive recovery later on. Conversely, the cerebellum showed a contralateral hypometabolism from days 7 to 14
after reperfusion. Neurological behavior showed major impaired outcome at day 1 after ischemia followed by a signicant
recovery of the sensorimotor function from days 7 to 28 after experimental stroke. Taken together, these results suggest that the
degree of CCD after cerebral ischemia might be predictive of neurological recovery.